Magnetic resonance imaging in psoriatic arthritis -- update on current status and future perspectives: a report from the GRAPPA 2010 annual meeting.
The potential of magnetic resonance imaging (MRI) for use in clinical practice and research has gained increasing interest over the last decade. International collaborative initiatives from GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) and/or OMERACT (Outcome Measures in Rheumatology) may contribute to facilitating research, identifying appropriate areas for use, and reaching consensus on the optimal examination technique. Accordingly, GRAPPA, a primary driver of international research in psoriasis and psoriatic arthritis (PsA), has focused on the current use and future development of MRI and other modern imaging modalities in PsA. This review, presented at the GRAPPA 2010 annual meeting, describes the current status of MRI in PsA, with a focus on its use in diagnosis, monitoring, and prediction of the disease course and treatment response. Important areas for future research are also outlined.
Department of Rheumatology, Copenhagen University Hospitals at Hvidovre and Glostrup, Denmark. mo@dadlnet.dk
Mikkel
M
Østergaard
René Panduro
RP
Poggenborg
D015535:Arthritis, Psoriatic / Q000175:diagnosis*; D006801:Humans; D008279:Magnetic Resonance Imaging; D012720:Severity of Illness Index; D016896:Treatment Outcome